Evan Greebel, a former Katten Muchin Rosenman partner convicted of conspiring to commit fraud with pharmaceutical executive Martin Shkreli, has lost his ability to appear before the U.S. Securities and Exchange Commission.

The order follows a New York court’s decision in early January to suspend Greebel from practicing law.